Clinical Trial Update: Bile Acids in Acute Insulin Resistance

View source ↗

Summary

A Columbia University-sponsored clinical trial on bile acids for acute insulin resistance has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Insulin Resistance

Snippet

Sponsor: Columbia University | Conditions: PI3K Gene Mutation, AKT Gene Mutation | Status: TERMINATED